Published in Women's Health Weekly, November 10th, 2005
Docetaxel is an anticancer agent which interferes with the ability of cancer cells to divide. It is indicated for the treatment of patients with locally advanced or metastatic breast cancer after the failure of prior chemotherapy; in combination with prednisone for the treatment of hormone-refractory metastatic prostate cancer; as a single...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly